先駆け審査指定制度対象品目の募集 against K.K. Serusido

株式会社 セルシード (薬事法)
薬事法Ministry of Health, Labour and WelfareOctober 5, 2017

Action summary

Company
K.K. SerusidoRomanized
Original: 株式会社 セルシード
Governing law
薬事法
薬事法
Action type
先駆け審査指定制度対象品目の募集
先駆け審査指定制度対象品目の募集
Action date
October 5, 2017
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

Suppression of stenosis and reduction of days until re-epithelialization after endoscopic submucosal dissection (ESD) for esophageal cancer using oral mucosa-derived esophageal cell sheet

Show original Japanese text

口腔粘膜由来食道細胞シート 食道がんにおける広範囲内視鏡的粘膜下層剥離術(ESD)後の狭窄の抑制及び再上皮化までの日数の短縮

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when K.K. Serusido has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
K.K. Serusido Romanized
Japanese name
株式会社 セルシード
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.